Cervical Screening with HIV or Low Immunity

Why Immunity Changes the Screening Rules

Cervical cancer is not really a story about a virus alone. It is a story about a virus and an immune system, and what happens when the second one cannot do its job. Most women meet high-risk HPV at some point; in most, immune surveillance suppresses and clears it long before it can do any damage. Reduced immunity interrupts that process at four separate points:

• The infection is less likely to clear. Persistence, not infection, is what causes cervical cancer — and persistence is exactly what a weakened immune system permits.
• More HPV types establish themselves. Women with suppressed immunity more often carry several high-risk types at once, which raises the chance that one of them persists.
• Precancerous change appears more often and progresses faster. The long ten-to-fifteen-year runway that makes cervical cancer so preventable can be shorter, which is the whole reason the screening interval is shortened too.
• Treated precancer recurs more readily. After a successful outpatient treatment, the risk of the same change returning is higher, so follow-up afterwards is closer and continues longer.
• None of this is a prediction about you. It is a description of risk across a population, and it is precisely what regular screening is designed to neutralise.

The biology behind that link — how HIV and immunosuppression raise cervical cancer risk, and what antiretroviral treatment does and does not change — is covered in more depth on our page about HIV, immunity and cervical cancer risk. For the general picture of how the disease develops, start with the cervical cancer overview.

Who Counts as Having Reduced Immunity?

HIV is the situation most people think of, but it is not the only one. If any of these describes you, say so when you book — it changes the schedule your doctor should be working to.

If you are not sure which group you fall into, bring your medication list to the appointment. The drugs you are on usually answer the question faster than the diagnosis does.

Two Things That Are Commonly Misunderstood

Both of these come up in clinic almost every week, and both lead to women stopping screening at exactly the point where continuing matters most.

What the Screening Schedule Actually Looks Like

Local practice varies, and your own doctor will set your interval based on your history rather than on a webpage. What follows is the shape of the schedule, so you know whether the plan you have been given fits the pattern — and so you know what to ask if it does not.

Start — from age 25, or from diagnosis

For women living with HIV, WHO guidance is to begin cervical screening at 25 rather than 30. If HIV is diagnosed later than that, screening starts at diagnosis rather than waiting for the next scheduled round. Transplant recipients and women beginning long-term immunosuppressive therapy are usually screened around the time that treatment starts, so there is a clean baseline to compare against.

Test — HPV DNA first, wherever it is available

WHO recommends HPV DNA detection as the primary screening test, and that recommendation applies with particular force here, because it is far better than cytology at identifying the women who need a closer look. Where cytology is used instead, or alongside, it is repeated more frequently to compensate. If the difference between the two tests is unfamiliar, our HPV test versus Pap smear comparison explains what each one measures.

Repeat — every three to five years after a negative test

A negative high-risk HPV result is still reassuring when immunity is low; it simply buys less time. Rather than the five-to-ten-year interval used for the general population, WHO advises re-screening women living with HIV every three to five years. Some units screen annually in the first year or two after an HIV diagnosis or after starting immunosuppression, before settling into the longer rhythm.

Act — a positive result is triaged, not watched

Where a woman with normal immunity might be observed and re-tested, a woman with suppressed immunity is more likely to be referred straight for colposcopy. That is deliberate: the margin for watchful waiting is smaller. Colposcopy is an outpatient look at the cervix under magnification, with a biopsy only if an abnormal area is seen, and at CION it is available in-house so there is no second referral.

Continue — after treatment, and for life

If precancerous change is found and treated, the follow-up afterwards is closer and lasts longer, because recurrence is more likely. And there is no age at which the schedule simply ends. Every cancer diagnosis at CION goes to a multidisciplinary tumour board before treatment is proposed, in line with NCCN, FIGO and ESMO guidance — and where a woman is on antiretroviral or immunosuppressive therapy, that treatment is coordinated with the team already managing it.

Standard Screening vs Screening With Reduced Immunity

A comparison of the general shape of each schedule. Your own plan is set by your doctor and may differ; use this to know what to ask, not to overrule advice you have already been given.

If a clinic visit is the obstacle rather than the schedule, read about HPV self-sampling and what it can and cannot do — though note that reduced immunity is one of the situations where a clinic-based test is preferred.

Confidentiality, Stigma, and Actually Getting Screened

The clinical part of this page is the easy part. The harder truth is that in Telangana, as in much of India, two separate stigmas overlap here: the stigma attached to HIV status, and the stigma attached to gynaecological examination. A woman managing both may decide the safest thing is to stay away from clinics altogether — which is precisely the decision that turns a preventable disease into a diagnosed one.

It is worth being concrete about what an appointment actually involves, because the imagined version is usually worse. You are seen in a private consultation room, not a shared space. A female attendant is present for any examination, and a woman doctor can be requested when you book — ask for it on the phone, before you arrive, and it is arranged. Your medical information is handled as confidential clinical data. You are not required to explain your history to anyone at reception, and you are not required to bring anyone with you. The consultation is deliberately unhurried — 45 minutes — because a five-minute appointment is not one in which anybody asks a difficult question.

If you would prefer to have the conversation before committing to a visit, use the callback form on this page. You can describe your situation in as much or as little detail as you want, and an oncologist will tell you what schedule applies to you and what the appointment would involve. Nothing is booked unless you ask for it to be.

One last point on cost, because it is the barrier nobody mentions. Screening tests are itemised and quoted before they are done, EMI facilities are available, and eligible patients are covered under Aarogyasri, CGHS, ECHS and ESI as well as by all major insurance TPAs. If money is the reason you have been putting this off, say so when you call — it is a solvable problem, and it is a far smaller one than a late diagnosis.

Why Women in Hyderabad Choose CION for Screening

Screening on a shorter interval only helps if the appointment is one you are willing to keep. Ours is built with that in mind.

A Shorter Interval Is Not Bad News

It is the adjustment that keeps a higher-risk situation under control. Most women screened on this schedule never develop anything that needs treating — because they were screened on this schedule.

Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It is not a diagnosis and cannot replace an examination, and it does not override the screening plan your own HIV, transplant or rheumatology team has set for you. Never stop or alter antiretroviral or immunosuppressive medication on the basis of anything you read here. If you have vaginal bleeding, unusual discharge or pelvic pain, please see a doctor rather than relying on any website.